Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling

Fig. 1

IGU suppresses Tfh cells in pSS patients. Flowcytometry analysis of (A) CD4+CXCR5+PD-1+, (B) CD4+CXCR5+ICOS+, (C) CD4+IL-21+, (D) CD4+CXCR5+PD-1+ICOS+ follicular T helper (Tfh) cells, (E) CD27+IgDswitched memory B cells, (F) CD38hiCD27hi plasmablasts, and (G) CD38hiCD138+ plasma cells isolated from peripheral blood of pSS patients (n = 13). Data were presented as mean ± SD. Data were obtained from independent experiments. *p < 0.05, **p < 0.01 by ANOVA

Back to article page